NOTARBARTOLO DI VILLAROSA, Monica
NOTARBARTOLO DI VILLAROSA, Monica
Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”.
2006-01-01 POMA P; NOTARBARTOLO DI VILLAROSA, M; LABBOZZETTA M; SANGUEDOLCE R; ALAIMO A; CARINA V; MAURICI A; CUSIMANO A; CERVELLO M; D'ALESSANDRO N
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
2020-01-01 Akula S.M.; Candido S.; Abrams S.L.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ramazzotti G.; Ratti S.; Follo M.Y.; Martelli A.M.; Murata R.M.; Rosalen P.L.; Bueno-Silva B.; Matias de Alencar S.; Falasca M.; Montalto G.; Cervello M.; Notarbartolo M.; Gizak A.; Rakus D.; Libra M.; McCubrey J.A.
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers.
2012-01-01 Poma, P; Notarbartolo DI Villarosa, M; Labbozzetta, M; Vivona, N; D’Alessandro, N
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma
2009-01-01 Notarbartolo Di Villarosa, M; Labbozzetta, M; Poma, P; Florena, AM; Porcasi, R; Cervello, M; Giannitrapani, L; Montalto, G; D'Alessandro, N
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma
2010-01-01 Notarbartolo Di Villarosa, M; Giannitrapani, L; Poma, P; Labbozzetta, M; Florena, AM; Porcasi, R; Muggeo, VMR; Sandonato, L; D'Alessandro, N; Montalto, G
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma
2013-01-01 Poma, P; Notarbartolo Di Villarosa, M; Labbozzetta, M; Vivona, N; D'Alessandro, N
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma
2012-01-01 Poma, P; Labbozzetta, M; Vivona, N; Porcasi, R; D'Alessandro, N; Notarbartolo Di Villarosa, M
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil.
2013-01-01 Labbozzetta, M; Vivona, N; Poma, P; Notarbartolo Di Villarosa, M; D'Alessandro, N
Antimigratory effects of a new NF-κB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-ƴ-butyrolactone, in 2D and 3D breast cancer models
2024-11-01 Paola Poma;Salvatrice Rigogliuso;Manuela Labbozzetta;Francesco Carfi Pavia;Camilla Carbone;Jun Ma;Alessandra Cusimano;Monica Notarbartolo
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia
2022-06-29 Manuela Labbozzetta; Paola Poma; Chiara Occhipinti; Maurizio Sajeva; Monica Notarbartolo
Antitumor effects of curcumin and of its combination with cisplatin or doxorubicin on human hepatic cancer cells: possible relationship to NF-kB activation and IAP gene expression.
2004-01-01 NOTARBARTOLO M; P POMA; D PERRI; M CERVELLO; N DALESSANDRO
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells
2008-01-01 SIMONI, D; RIZZI, M; RONDANIN, R; BARUCHELLO, R; MARCHETTI, P; INVIDIATA, F; LABBOZZETTA, M; POMA, P; CARINA, V; NOTARBARTOLO DI VILLAROSA, M; ALAIMO, A; D'ALESSANDRO, N
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression.
2005-01-01 NOTARBARTOLO DI VILLAROSA M; P POMA; M LABBOZZETTA; A ALAIMO; M CERVELLO; N D'ALESSANDRO
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION
2005-01-01 NOTARBARTOLO DI VILLAROSA, M; POMA, P; PERRI, D; DUSONCHET, L; CERVELLO, M; D'ALESSANDRO, N
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production
2005-01-01 LABBOZZETTA M; CARINA V; NOTARBARTOLO M; POMA P; MAURICI A; CERVELLO M; D'ALESSANDRO N
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production.
2005-01-01 NOTARBARTOLO M; LABBOZZETTA M; POMA P; CARINA V; ALAIMO A; MAURICI A; CERVELLO M; DALESSANDRO N
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell
2019-09-01 Paola Poma; Manuela Labbozzetta; James A. McCubrey; Aro Vonjy Ramarosandratana; Maurizio Sajeva; Pietro Zito; Monica Notarbartolo
Bioactive triterpenes of protium heptaphyllum gum resin extract display cholesterol-lowering potential
2021-03-06 Mannino G.; Iovino P.; Lauria A.; Genova T.; Asteggiano A.; Notarbartolo Monica; Porcu A.; Serio G.; Chinigo G.; Occhipinti A.; Capuzzo A.; Medana C.; Munaron L.; Gentile C.
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View
2020-01-01 Labbozzetta Manuela; Notarbartolo Monica; Poma Paola
Cancer therapy and treatments during COVID-19 era
2020-01-01 Akula S.M.; Abrams S.L.; Steelman L.S.; Candido S.; Libra M.; Lerpiriyapong K.; Cocco L.; Ramazzotti G.; Ratti S.; Follo M.Y.; Martelli A.M.; Blalock W.L.; Piazzi M.; Montalto G.; Cervello M.; Notarbartolo M.; Basecke J.; McCubrey J.A.